Dexpanthenol

PreclinicalSmall molecule

Bayer

Dexpanthenol is one of 6 small molecule programs targeting Wound. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

WoundNot yet recruiting

Chronic WoundsNot yet recruiting

WoundPreclinical

Not yet recruiting

Chronic WoundsPreclinical

Not yet recruiting

Competition

Competitive Landscape

4 competitors in Wound

#DrugCompanyPhaseTrials

Peridex

DDexcel Pharma Technologies Ltd.

Preclinical

1 2

Kenalog

BBassett Healthcare

Preclinical

1 3

Timolol Maleate

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 1

1 4

Silver Nitrate

MMansoura University Hospital

Preclinical

1 5

Dexpanthenol

Bayer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Chronic Wounds

NCT07395674

Clinical

Trials by Indication[1]

Cheilitis1 trial

Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

Terminated·HHospital de Clinicas de Porto Alegre·Phase 1·NCT04219358·49 enrolled

ESS1 trial

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

Completed· Bayer logo

Bayer·Phase 4·NCT00859196·15 enrolled

NEC1 trial

Comparative Safety Study of New Sinecort Formulation Versus Positive Control

Completed· Bayer logo

Bayer·Phase 1·NCT00885937·33 enrolled

Pilot Study1 trial

Pilot Study to Assess Number of Patients for Main Trial

Completed· Bayer logo

Bayer·Phase 4·NCT02734628·28 enrolled

Oral Mucositis1 trial

Dexpanthenol Mouthwash to Treat Oral Mucositis

Unknown status·SShahid Beheshti University of Medical Sciences·Phase 2·NCT01318889·30 enrolled

1 more indication

Chronic Wounds1 trial

Evaluation of the Effect of Subcutaneous Dexpanthenol Administration on Wound Epithelialization: A Pilot Randomized Controlled Study

Not yet recruiting·DDilara CANBAY OZDEMIR·Preclinical·NCT07395674·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Dexpanthenol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexpanthenol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexpanthenol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Bayer

Dexpanthenol

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Cheilitis1 trial

ESS1 trial

NEC1 trial

Pilot Study1 trial

Oral Mucositis1 trial

Chronic Wounds1 trial

References

Drug Info

Quick Facts

Related News